L. McMillian

发表

G.O.17 Results of a phase 2 open-label study of ISIS-SMNRx in patients with infantile (Type 1) spinal muscular atrophy

R. Finkel, C. Bennett, J. Montes, 2014, Neuromuscular Disorders.